0001415889-19-000742.txt : 20190617
0001415889-19-000742.hdr.sgml : 20190617
20190617214828
ACCESSION NUMBER: 0001415889-19-000742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190613
FILED AS OF DATE: 20190617
DATE AS OF CHANGE: 20190617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schramm Vern Lee
CENTRAL INDEX KEY: 0001719553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37853
FILM NUMBER: 19902558
MAIL ADDRESS:
STREET 1: 1300 MORRIS PARK AVE.
STREET 2: BIOCHEMISTRY DEPT.
CITY: BRONX
STATE: NY
ZIP: 10461
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AzurRx BioPharma, Inc.
CENTRAL INDEX KEY: 0001604191
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
BUSINESS PHONE: 646-699-7855
MAIL ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharma d'Azur, Inc.
DATE OF NAME CHANGE: 20140331
4
1
form4-06172019_060616.xml
X0306
4
2019-06-13
0001604191
AzurRx BioPharma, Inc.
AZRX
0001719553
Schramm Vern Lee
C/O AZURRX BIOPHARMA, INC.
760 PARKSIDE AVE STE 304
BROOKLYN
NY
11226
true
false
false
false
Common Stock
2019-06-13
4
A
0
30000
0
A
75000
D
Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors.
/s/ Maged Shenouda, Attorney-in-Fact
2019-06-17